全文获取类型
收费全文 | 2245篇 |
免费 | 209篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 98篇 |
妇产科学 | 33篇 |
基础医学 | 336篇 |
口腔科学 | 77篇 |
临床医学 | 265篇 |
内科学 | 459篇 |
皮肤病学 | 48篇 |
神经病学 | 202篇 |
特种医学 | 253篇 |
外科学 | 216篇 |
综合类 | 84篇 |
一般理论 | 2篇 |
预防医学 | 174篇 |
眼科学 | 67篇 |
药学 | 65篇 |
1篇 | |
肿瘤学 | 88篇 |
出版年
2021年 | 21篇 |
2020年 | 19篇 |
2018年 | 30篇 |
2017年 | 17篇 |
2016年 | 20篇 |
2015年 | 37篇 |
2014年 | 42篇 |
2013年 | 90篇 |
2012年 | 64篇 |
2011年 | 77篇 |
2010年 | 85篇 |
2009年 | 74篇 |
2008年 | 73篇 |
2007年 | 87篇 |
2006年 | 63篇 |
2005年 | 62篇 |
2004年 | 47篇 |
2003年 | 57篇 |
2002年 | 41篇 |
2001年 | 39篇 |
2000年 | 37篇 |
1999年 | 65篇 |
1998年 | 97篇 |
1997年 | 85篇 |
1996年 | 68篇 |
1995年 | 67篇 |
1994年 | 48篇 |
1993年 | 56篇 |
1992年 | 36篇 |
1991年 | 49篇 |
1990年 | 45篇 |
1989年 | 63篇 |
1988年 | 66篇 |
1987年 | 47篇 |
1986年 | 64篇 |
1985年 | 56篇 |
1984年 | 24篇 |
1983年 | 32篇 |
1982年 | 26篇 |
1981年 | 33篇 |
1980年 | 28篇 |
1979年 | 30篇 |
1978年 | 31篇 |
1977年 | 37篇 |
1976年 | 33篇 |
1975年 | 24篇 |
1974年 | 20篇 |
1973年 | 20篇 |
1972年 | 20篇 |
1970年 | 30篇 |
排序方式: 共有2474条查询结果,搜索用时 15 毫秒
1.
2.
D F Levinson 《Clinical therapeutics》1991,13(3):326-352
The literature on the pharmacologic treatment of schizophrenia and schizoaffective disorders is reviewed (116 references). All clinically active antipsychotic drugs share the ability to block postsynaptic dopamine receptors in the central nervous system. Their potencies vary, chlorpromazine and thioridazine being the least potent and fluphenazine and haloperidol the most potent. The adverse effects of the neuroleptics include acute dystonia, parkinsonian symptoms (extrapyramidal symptoms), akathisia, tardive dyskinesia, and tardive dystonia. When used at equipotent doses, all classic neuroleptics now available are equally effective in the treatment of schizophrenia. Choice of drug is based on adverse effects and patient response. The neuroleptics are effective in most acute exacerbations of schizophrenia and for the prevention or mitigation of relapse. Their effects are more pronounced on the positive symptoms of schizophrenia, such as hallucinations, delusions, disordered thinking, and paranoia, than on the negative symptoms, such as deficits in social interaction, emotional expression, and motivation. Strategies for acute and maintenance treatment and for the management of treatment-resistant patients are reviewed. The pharmacology and clinical use of the newer atypical neuroleptics, particularly clozapine, and their adverse effects are discussed. 相似文献
3.
4.
Pyomyositis: characteristics at CT and MR imaging 总被引:9,自引:0,他引:9
5.
AJ Larner MRCP 《International journal of clinical practice》1994,48(5):272-274
SUMMARY A case is reported of pseudohyperphosphataemia in association with a monoclonal gammopathy of undetermined significance. 相似文献
6.
7.
8.
D De AJ Kanwar S Handa 《Journal of the European Academy of Dermatology and Venereology》2006,20(7):853-859
BACKGROUND: Diagnosis of atopic dermatitis (AD) depends on clinical features because no definitive diagnostic test exists. Criteria proposed by Hanifin and Rajka (Acta Derm Venereol (Stockh) 1980; Suppl 92: 44-47) were acceptable for hospital-based studies but were found not to be suitable for field studies. A UK working party formulated clinical diagnostic criteria that could be used in both hospital and epidemiological settings. Validation studies of the criteria showed widely variable results, probably due to different clinical settings and ethnicity. AIM AND OBJECTIVE: This study was undertaken to validate Hanifin and Rajka's criteria and to assess the comparative efficacy of their criteria and the UK working party's diagnostic criteria in the diagnosis of AD in a hospital setting in North India. SUBJECTS AND METHODS: This study serially included 101 patients with AD and 48 controls of paediatric age group. The study period was from July 2003 to December 2004. RESULTS: Hanifin and Rajka's criteria (sensitivity 96%, specificity 93.75%, positive predictive value 97% (PPV) and negative predictive value (NPV) 91.84%) had a statistical advantage over the UK working party's diagnostic criteria (sensitivity 86%, specificity 95.83%, PPV 97.75% and NPV 76.67%), with a P-value < 0.005. 相似文献
9.
SUMMARY Impotence is a common symptom which can cause considerable distress to both the sufferer and his partner. The use of pharmacotherapy to improve erectile function will continue to increase as safe and effective drugs are developed. However, restoring erectile function should not be the only treatment objective. It is also essential to address personal and emotional factors in the sufferer, conflicts in his relationship with his partner, and sexual problems in his partner, all of which may be instrumental in causing or maintaining the presenting impotence. We advocate a combined approach with appropriate medical treatment and sex and couple therapy 相似文献
10.
G M Simpson K G Yadalam D F Levinson M J Stephanos E S Lo T B Cooper 《Journal of clinical psychopharmacology》1990,10(6):417-421
Fluphenazine decanoate is commonly used as part of maintenance treatment of schizophrenia, but its pharmacokinetics are poorly understood. We administered a single intramuscular dose of fluphenazine decanoate to nine patients and found that plasma fluphenazine level did not decline to 50% of the peak level by day 26 in any of the patients. This means that it has a long half-life measurable in months rather than weeks. 相似文献